Interactions between Microbiome and DME (MICBIO)
|
Bacteria: Actinobacteria |
Bifidobacterium adolescentis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bifidobacterium adolescentis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bifidobacterium breve (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bifidobacterium breve co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bifidobacterium longum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bifidobacterium longum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bifidobacterium ruminatum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Bupropion |
Click to Show/Hide the Detail |
Drug ID |
DR0247
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bifidobacterium ruminatum co-metabolize the drug Bupropion, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bifidobacterium ruminatum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Fluvoxamine maleate |
Click to Show/Hide the Detail |
Drug ID |
DR0740
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bifidobacterium ruminatum co-metabolize the drug Fluvoxamine maleate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Eggerthella lenta (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Eszopiclone |
Click to Show/Hide the Detail |
Drug ID |
DR0652
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Eggerthella lenta co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Nocardia farcinica (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Rifampicin |
Click to Show/Hide the Detail |
Drug ID |
DR1420
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Nocardia farcinica co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [6] |
Tsukamurella paurometabola (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Isoniazid |
Click to Show/Hide the Detail |
Drug ID |
DR0886
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Tsukamurella paurometabola co-metabolize the drug Isoniazid, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [8], [9] |
Bacteria: Bacteroidetes |
Alistipes indistinctus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Alistipes indistinctus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides coprophilus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Carvedilol |
Click to Show/Hide the Detail |
Drug ID |
DR0282
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides coprophilus co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
Eszopiclone |
Click to Show/Hide the Detail |
Drug ID |
DR0652
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides coprophilus co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Bacteroides dorei (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Carvedilol |
Click to Show/Hide the Detail |
Drug ID |
DR0282
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides dorei co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides dorei co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides eggerthii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides eggerthii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Carvedilol |
Click to Show/Hide the Detail |
Drug ID |
DR0282
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides fragilis co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides fragilis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides intestinalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides intestinalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides ovatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Carvedilol |
Click to Show/Hide the Detail |
Drug ID |
DR0282
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides ovatus co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides ovatus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides sartorii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Carvedilol |
Click to Show/Hide the Detail |
Drug ID |
DR0282
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides sartorii co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides sartorii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides stercoris (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides stercoris co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Carvedilol |
Click to Show/Hide the Detail |
Drug ID |
DR0282
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides thetaiotaomicron co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides thetaiotaomicron co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides uniformis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides uniformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides vulgatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides vulgatus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Verapamil hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR1681
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides vulgatus co-metabolize the drug Verapamil hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Carvedilol |
Click to Show/Hide the Detail |
Drug ID |
DR0282
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides xylanisolvens co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides xylanisolvens co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Odoribacter splanchnicus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Odoribacter splanchnicus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Parabacteroides distasonis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Parabacteroides distasonis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Parabacteroides johnsonii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Parabacteroides johnsonii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Parabacteroides merdae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Parabacteroides merdae co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Prevotella copri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Prevotella copri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteria: Chlamydiae |
Chlamydia muridarum (chlamydias) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Folic acid |
Click to Show/Hide the Detail |
Drug ID |
DR0742
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Chlamydia muridarum co-metabolize the drug Folic acid, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [13], [14] |
Bacteria: Cyanobacteria |
Synechococcus elongatus (cyanobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Isoniazid |
Click to Show/Hide the Detail |
Drug ID |
DR0886
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Synechococcus elongatus co-metabolize the drug Isoniazid, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [15] |
Bacteria: Firmicutes |
Anaerobutyricum hallii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Eszopiclone |
Click to Show/Hide the Detail |
Drug ID |
DR0652
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Anaerobutyricum hallii co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Anaerobutyricum hallii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Anaerococcus hydrogenalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Eszopiclone |
Click to Show/Hide the Detail |
Drug ID |
DR0652
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Anaerococcus hydrogenalis co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Bacillus megaterium (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Acetaminophen |
Click to Show/Hide the Detail |
Drug ID |
DR0037
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacillus megaterium co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [17] |
Chlorzoxazone |
Click to Show/Hide the Detail |
Drug ID |
DR0312
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacillus megaterium co-metabolize the drug Chlorzoxazone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[18], [19], [17] |
Bacteroides pectinophilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Bacteroides pectinophilus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Blautia hansenii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Carvedilol |
Click to Show/Hide the Detail |
Drug ID |
DR0282
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Blautia hansenii co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Blautia hansenii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Fluvoxamine maleate |
Click to Show/Hide the Detail |
Drug ID |
DR0740
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Blautia hansenii co-metabolize the drug Fluvoxamine maleate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Sildenafil citrate |
Click to Show/Hide the Detail |
Drug ID |
DR1481
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Blautia hansenii co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [2] |
Clostridioides difficile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Acetaminophen |
Click to Show/Hide the Detail |
Drug ID |
DR0037
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Clostridioides difficile co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [21] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Clostridioides difficile co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Sildenafil citrate |
Click to Show/Hide the Detail |
Drug ID |
DR1481
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Clostridioides difficile co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [2] |
Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Eszopiclone |
Click to Show/Hide the Detail |
Drug ID |
DR0652
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Clostridium botulinum co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Clostridium botulinum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Fluvoxamine maleate |
Click to Show/Hide the Detail |
Drug ID |
DR0740
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Clostridium botulinum co-metabolize the drug Fluvoxamine maleate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Sildenafil citrate |
Click to Show/Hide the Detail |
Drug ID |
DR1481
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Clostridium botulinum co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [2] |
Clostridium sporogenes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Carvedilol |
Click to Show/Hide the Detail |
Drug ID |
DR0282
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Clostridium sporogenes co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Clostridium sporogenes co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Clostridium symbiosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Eszopiclone |
Click to Show/Hide the Detail |
Drug ID |
DR0652
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Clostridium symbiosum co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Dorea formicigenerans (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Dorea formicigenerans co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Enterocloster asparagiformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Enterocloster asparagiformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Enterocloster bolteae (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Enterocloster bolteae co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Enterococcus faecalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Acetaminophen |
Click to Show/Hide the Detail |
Drug ID |
DR0037
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Enterococcus faecalis co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [21] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Enterococcus faecalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Erysipelatoclostridium ramosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Erysipelatoclostridium ramosum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Eubacterium rectale (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Eszopiclone |
Click to Show/Hide the Detail |
Drug ID |
DR0652
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Eubacterium rectale co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Eubacterium rectale co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Eubacterium ventriosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Eubacterium ventriosum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Faecalibacterium prausnitzii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Menadione |
Click to Show/Hide the Detail |
Drug ID |
DR1022
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Faecalibacterium prausnitzii co-metabolize the drug Menadione, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [23] |
Holdemanella biformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Carvedilol |
Click to Show/Hide the Detail |
Drug ID |
DR0282
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Holdemanella biformis co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Holdemanella biformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Lactobacillus casei (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Folic acid |
Click to Show/Hide the Detail |
Drug ID |
DR0742
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Lactobacillus casei co-metabolize the drug Folic acid, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [24], [25] |
Lactobacillus johnsonii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Tegafur |
Click to Show/Hide the Detail |
Drug ID |
DR1539
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Lactobacillus johnsonii co-metabolize the drug Tegafur, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [27] |
Lactobacillus reuteri (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Lactobacillus reuteri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Marvinbryantia formatexigens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Eszopiclone |
Click to Show/Hide the Detail |
Drug ID |
DR0652
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Marvinbryantia formatexigens co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Roseburia intestinalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Carvedilol |
Click to Show/Hide the Detail |
Drug ID |
DR0282
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Roseburia intestinalis co-metabolize the drug Carvedilol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Roseburia intestinalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Ruminococcus gnavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Ruminococcus gnavus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Ruminococcus lactaris (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Eszopiclone |
Click to Show/Hide the Detail |
Drug ID |
DR0652
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Ruminococcus lactaris co-metabolize the drug Eszopiclone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Ruminococcus lactaris co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Subdoligranulum variabile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Subdoligranulum variabile co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteria: Proteobacteria |
Citrobacter freundii (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Acetaminophen |
Click to Show/Hide the Detail |
Drug ID |
DR0037
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Citrobacter freundii co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [21] |
Enterobacter cancerogenus (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Enterobacter cancerogenus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Escherichia coli (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Acetaminophen |
Click to Show/Hide the Detail |
Drug ID |
DR0037
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Escherichia coli co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [21] |
Bupropion |
Click to Show/Hide the Detail |
Drug ID |
DR0247
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Escherichia coli co-metabolize the drug Bupropion, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Escherichia coli co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Folic acid |
Click to Show/Hide the Detail |
Drug ID |
DR0742
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Escherichia coli co-metabolize the drug Folic acid, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [28], [29] |
Neisseria sicca (beta-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Ethanol |
Click to Show/Hide the Detail |
Drug ID |
DR0655
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Neisseria sicca co-metabolize the drug Ethanol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [31] |
Proteus penneri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Proteus penneri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Providencia stuartii (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Providencia stuartii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Pseudomonas putida (gamma-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Nicotine |
Click to Show/Hide the Detail |
Drug ID |
DR1148
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Pseudomonas putida co-metabolize the drug Nicotine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [33] |
Salmonella enterica (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0720
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Salmonella enterica co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Menadione |
Click to Show/Hide the Detail |
Drug ID |
DR1022
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Salmonella enterica co-metabolize the drug Menadione, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [34], [35] |
Fungi: Ascomycota |
Saccharomyces cerevisiae (ascomycota) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Acetaminophen |
Click to Show/Hide the Detail |
Drug ID |
DR0037
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) metabolizes the drug Acetaminophen, and Saccharomyces cerevisiae further metabolizes its metabolite (1-Phenyl-1,2-propanedione), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[16], [21] |
Archaea: Euryarchaeota |
Methanobrevibacter oralis (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Rifampicin |
Click to Show/Hide the Detail |
Drug ID |
DR1420
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Methanobrevibacter oralis co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [36] |
Methanobrevibacter smithii (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Rifampicin |
Click to Show/Hide the Detail |
Drug ID |
DR1420
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Methanobrevibacter smithii co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [36] |
Methanomassiliicoccus luminyensis (thermoplasmata) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Rifampicin |
Click to Show/Hide the Detail |
Drug ID |
DR1420
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Methanomassiliicoccus luminyensis co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [36] |
Methanosphaera stadtmanae (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Rifampicin |
Click to Show/Hide the Detail |
Drug ID |
DR1420
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 2E1 (CYP2E1) and Methanosphaera stadtmanae co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [36] |
|
|
|
|
|
|